Stock SBH SANGUI BIOTECH INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sangui Biotech International, Inc.

Equities

SBH

US80105B1017

Biotechnology & Medical Research

End-of-day quote Hanseatische Wertpapierboerse Hamburg
Other stock markets
 07:00:00 2024-03-19 pm EDT 		5-day change 1st Jan Change
0.002 EUR -20.00% Intraday chart for Sangui Biotech International, Inc. -.--% -33.33%
Feb. 15 Sangui Biotech International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 Sangui Biotech International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI

Valuation

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Capitalization 1 6.842 6.135 5.605 3.205 5.153 3.089
Enterprise Value (EV) 1 6.938 6.358 6.055 3.883 5.943 3.883
P/E ratio -21.1 x -30.4 x -17.1 x -16.5 x -25.6 x -51.8 x
Yield - - - - - -
Capitalization / Revenue 101 x 79.5 x 63.7 x 111 x 78.6 x 44.6 x
EV / Revenue 103 x 82.4 x 68.8 x 134 x 90.6 x 56.1 x
EV / EBITDA - - - -21,551,166 x -39,532,682 x -28,003,695 x
EV / FCF -35 x -37 x -32.5 x -28.4 x -74.1 x -57.8 x
FCF Yield -2.86% -2.7% -3.08% -3.53% -1.35% -1.73%
Price to Book 19.5 x 23.1 x 114 x -38.7 x -23.1 x -12.9 x
Nbr of stocks (in thousands) 187,108 188,398 199,242 203,302 206,902 209,902
Reference price 2 0.0366 0.0326 0.0281 0.0158 0.0249 0.0147
Announcement Date 10/16/17 9/28/18 10/8/19 9/30/20 9/28/21 9/28/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net sales 1 0.0677 0.0772 0.088 0.0289 0.0656 0.0692
EBITDA - - - -0.1802 -0.1503 -0.1387
EBIT 1 -0.3168 -0.208 -0.3376 -0.1814 -0.1511 -0.1394
Operating Margin -468.27% -269.66% -383.67% -627.34% -230.45% -201.54%
Earnings before Tax (EBT) 1 -0.3296 -0.2158 -0.3425 -0.1985 -0.2037 -0.0633
Net income 1 -0.309 -0.2018 -0.3236 -0.1927 -0.1989 -0.0593
Net margin -456.71% -261.57% -367.7% -666.58% -303.26% -85.72%
EPS 2 -0.001731 -0.001072 -0.001641 -0.000955 -0.000974 -0.000284
Free Cash Flow 1 -0.1984 -0.1718 -0.1863 -0.137 -0.0802 -0.0671
FCF margin -293.26% -222.63% -211.74% -473.68% -122.25% -97.04%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/16/17 9/28/18 10/8/19 9/30/20 9/28/21 9/28/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net Debt 1 0.1 0.22 0.45 0.68 0.79 0.79
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - - - -3.765 x -5.255 x -5.729 x
Free Cash Flow 1 -0.2 -0.17 -0.19 -0.14 -0.08 -0.07
ROE (net income / shareholders' equity) 130% 70.6% 72.6% 30% 25.4% 7.16%
ROA (Net income/ Total Assets) -194% -133% -233% -111% -72.8% -65.8%
Assets 1 0.1593 0.1519 0.1388 0.1737 0.2731 0.0901
Book Value Per Share 2 0 0 0 -0 -0 -0
Cash Flow per Share 2 0 0 0 0 0 0
Capex - - - 0 - -
Capex / Sales - - - 10.71% - -
Announcement Date 10/16/17 9/28/18 10/8/19 9/30/20 9/28/21 9/28/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SANGUI BIOTECH INTERNATIONAL, INC. Stock Sangui Biotech International, Inc.
-33.33% 448K
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SBH Stock
  4. Financials Sangui Biotech International, Inc.